Oracle Health Sciences InForm Cloud Service 6.1 Helps Life Sciences Organizations Accelerate Study Start-Up and Expand Risk-Based Monitoring Precision

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. MU
5. META
6. FDX
7. IBM
8. PRIM
9. ACN
10. USO

Go back to Oracle Health Sciences InForm Cloud Service 6.1 Helps Life Sciences Organizations Accelerate Study Start-Up and Expand Risk-Based Monitoring Precision

Wedbush Cuts Price Target Following Oracle (ORCL) EPS Miss

June 18, 2015 8:33 AM EDT

Wedbush maintains a Neutral rating on Oracle (NYSE: ORCL), and cut the price target to $40.00 (from $42.00), following F4Q results. ORCL reported EPS of $0.78 compared to $0.86 consensus. ORCL guided EPS to $0.56-$0.59.

Analyst Steve Koenig commented, "ORCL missed consensus... More

Cantor Fitzgerald Remains Bullish Following Oracle (ORCL) F4Q15 Results

June 18, 2015 8:12 AM EDT

Cantor Fitzgerald reiterates a Buy rating and $48.00 price target on Oracle (NYSE: ORCL) following F4Q15 results. EPS of $0.78 fell short of consensus at $0.86. Oracle expects nonGAAP sales to be up 5-8% YoY in CC and pro forma EPS in CC to be $0.56-0.59.... More

Jefferies Reiterates Hold Following Oracle (ORCL) F4Q Miss

June 18, 2015 7:36 AM EDT

Jefferies maintains a Hold rating and $41.00 price target on Oracle (NYSE: ORCL) following F4Q results. Reported Non-GAAP EPS of $0.78 was below consensus of $0.87. ORCL reported revenues of $10.706B, compared to $10.972B consensus.

Analyst John DiFucci commented, "ORCL reported F4Q results... More